| Peter Kolodychuk, | |
|
2116 E Section St Ste B17, Mount Vernon, WA 98274-9124 | |
| (360) 588-4241 | |
| Not Available |
| Full Name | Peter Kolodychuk |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 2116 E Section St Ste B17, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215545165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Center For Sports Medicine And Physical Therapy Inc | 1759278542 | 55 |
News Archive
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
According to the most recent Hospital Value Index™ results, a study that analyzed data from more than 4,500 hospitals across the United States, hospitals in the largest U.S. cities generally offer a low value of patient care compared to elsewhere in the country.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
The Centers for Disease Control and Prevention (CDC) has awarded $4 million to the Johns Hopkins Center for Injury Research and Policy at the Bloomberg School of Public Health to help the Center continue its mission of making discoveries that save lives and reduce costs due to injuries.
The Pennsylvania House of Representatives has passed a resolution declaring the week of May 24, 2010 as "Duchenne Muscular Dystrophy Awareness Week" to help honor the work of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy.
› Verified 4 days ago
| Provider Name | Northwest Center For Sports Medicine & Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1982755070 PECOS PAC ID: 1759278542 Enrollment ID: O20150728005642 |
News Archive
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
According to the most recent Hospital Value Index™ results, a study that analyzed data from more than 4,500 hospitals across the United States, hospitals in the largest U.S. cities generally offer a low value of patient care compared to elsewhere in the country.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
The Centers for Disease Control and Prevention (CDC) has awarded $4 million to the Johns Hopkins Center for Injury Research and Policy at the Bloomberg School of Public Health to help the Center continue its mission of making discoveries that save lives and reduce costs due to injuries.
The Pennsylvania House of Representatives has passed a resolution declaring the week of May 24, 2010 as "Duchenne Muscular Dystrophy Awareness Week" to help honor the work of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Kolodychuk, 1200 Corporate Dr Ste 400, Birmingham, AL 35242-5424 Ph: () - | Peter Kolodychuk, 2116 E Section St Ste B17, Mount Vernon, WA 98274-9124 Ph: (360) 588-4241 |
News Archive
Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients.
According to the most recent Hospital Value Index™ results, a study that analyzed data from more than 4,500 hospitals across the United States, hospitals in the largest U.S. cities generally offer a low value of patient care compared to elsewhere in the country.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that in collaboration with OXiGENE, Professor Gordon Rustin and colleagues from the Mount Vernon Cancer Research Centre, UK and other institutions in the United Kingdom, reported positive final data from an investigator-sponsored Phase 1 study of OXi4503 in patients with solid tumors.
The Centers for Disease Control and Prevention (CDC) has awarded $4 million to the Johns Hopkins Center for Injury Research and Policy at the Bloomberg School of Public Health to help the Center continue its mission of making discoveries that save lives and reduce costs due to injuries.
The Pennsylvania House of Representatives has passed a resolution declaring the week of May 24, 2010 as "Duchenne Muscular Dystrophy Awareness Week" to help honor the work of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy.
› Verified 4 days ago
Keelymae J Regan, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1500 Continental Pl, Mount Vernon, WA 98273 Phone: 360-424-7041 Fax: 360-424-2456 | |
Lane Williams, Physical Therapist Medicare: Medicare Enrolled Practice Location: 110 N Laventure Rd Ste A, Mount Vernon, WA 98273 Phone: 360-428-2700 Fax: 360-428-2701 | |
Dr. Dana Sturtz, DPT, GCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-2184 | |
Urban Fitness And Health Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 E College Way, Mount Vernon, WA 98273 Phone: 206-999-9310 | |
Kimberly Kae Miller, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1401 S Laventure Rd, Mount Vernon, WA 98274 Phone: 360-424-2400 Fax: 360-424-2418 | |
Sarah Louise Johnston, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-2699 | |
Jessica Ann Younger, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Childrens Therapy Department, Mount Vernon, WA 98274 Phone: 360-814-2696 Fax: 360-814-5467 |